CRISPR gene editing for sickle cell disease: one disease, differentiated approaches

Lisa A Michaels, MD

Chief Medical Officer, Editas Medicine

Bruce E Eaton, PhD

Chief Business Officer, Editas Medicine

Please enter your email to access content Read now